79 related articles for article (PubMed ID: 19942961)
1. Predictive value of cellular immune response in cervical cancer.
Ancuta E; Ancuţa C; Zugun-Eloae F; Iordache C; Chirieac R; Carasevici E
Rom J Morphol Embryol; 2009; 50(4):651-5. PubMed ID: 19942961
[TBL] [Abstract][Full Text] [Related]
2. Potential value of in situ cellular immune response in HPV subtype 16 and 18 positive cervical cancer.
Ancuţa E; Buţureanu S; Zugun-Eloae F; Anton CR; Ancuţa C; Diţescu D; Anton E
Rom J Morphol Embryol; 2014; 55(3):817-22. PubMed ID: 25329108
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.
Nedergaard BS; Ladekarl M; Nyengaard JR; Nielsen K
Gynecol Oncol; 2008 Jan; 108(1):106-11. PubMed ID: 17945335
[TBL] [Abstract][Full Text] [Related]
4. Tumor biomarkers in cervical cancer: focus on Ki-67 proliferation factor and E-cadherin expression.
Ancuţa E; Ancuţa C; Cozma LG; Iordache C; Anghelache-Lupaşcu I; Anton E; Carasevici E; Chirieac R
Rom J Morphol Embryol; 2009; 50(3):413-8. PubMed ID: 19690767
[TBL] [Abstract][Full Text] [Related]
5. Corelation of lymphocytic infiltrates with the prognosis of recurrent colo-rectal cancer.
Makkai-Popa ST; Luncă S; Dimofte G; Vrânceanu A; Franciug D; Ivanov I; Zugun F; Târcoveanu E; Carasevici E
Chirurgia (Bucur); 2013; 108(6):859-65. PubMed ID: 24331327
[TBL] [Abstract][Full Text] [Related]
6. The clinical utility of the local inflammatory response in colorectal cancer.
Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
[TBL] [Abstract][Full Text] [Related]
7. Neoangiogenesis in cervical cancer: focus on CD34 assessment.
Ancuţa C; Ancuţa E; Zugun-Eloae F; Carasevici E
Rom J Morphol Embryol; 2010; 51(2):289-94. PubMed ID: 20495745
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.
Ajili F; Kourda N; Darouiche A; Chebil M; Boubaker S
Ultrastruct Pathol; 2013 Feb; 37(1):56-61. PubMed ID: 23383616
[TBL] [Abstract][Full Text] [Related]
9. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
Roxburgh CS; McMillan DC
Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
[TBL] [Abstract][Full Text] [Related]
10. Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer.
Nedergaard BS; Ladekarl M; Thomsen HF; Nyengaard JR; Nielsen K
Br J Cancer; 2007 Oct; 97(8):1135-8. PubMed ID: 17940503
[TBL] [Abstract][Full Text] [Related]
11. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
12. Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels.
Strickler HD; Escoffery C; Rattray C; Fuchs D; Wachter H; Manns A; Schiffman MH; Cranston B; Hanchard B; Blattner WA
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):295-8. PubMed ID: 7606206
[TBL] [Abstract][Full Text] [Related]
13. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.
Braicu EI; Gasimli K; Richter R; Nassir M; Kümmel S; Blohmer JU; Yalcinkaya I; Chekerov R; Ignat I; Ionescu A; Mentze M; Fotopoulou C; Pop C; Lichtenegger W; Sehouli J; ;
Anticancer Res; 2014 Jan; 34(1):385-91. PubMed ID: 24403492
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate.
Giuşcă SE; Zugun FE; Târcoveanu E; Carasevici E; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2010; 51(1):73-9. PubMed ID: 20191123
[TBL] [Abstract][Full Text] [Related]
15. The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.
Curtis NJ; Primrose JN; Thomas GJ; Mirnezami AH; Ottensmeier CH
Eur J Surg Oncol; 2012 Oct; 38(10):889-96. PubMed ID: 22721580
[TBL] [Abstract][Full Text] [Related]
16. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
17. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.
Liu D; Baltayan A; Naritoku WY; Barr NJ; Young LL; Chaiwun B; Tsao-Wei DD; Groshen SL; Taylor CR; Torloni H; Neville AM; Cote RJ; Imam SA
Anticancer Res; 2000; 20(3A):1451-61. PubMed ID: 10928056
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
19. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
20. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
Ishiguro T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
